Acute Beetroot Juice Supplementation in Amateur Climbers

January 26, 2022 updated by: Luis Berlanga, Universidad Francisco de Vitoria

Acute Effects of Beetroot Juice Supplementation Among Neuromuscular Performance in Amateur Climbers

Whereas beetroot juice (BJ) supplementation is shown to increase physical performance in endurance activities, its benefits in neuromuscular function and strength performance has been barely studied. In this cross-over randomized placebo-controlled study, we investigated the effects of BJ acute supplementation in improving neuromuscular performance in amateur climbers

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
    • Madrid
      • Pozuelo De Alarcón, Madrid, Spain, 28223
        • Universidad Francisco de Vitoria

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • more than 18 years
  • active climbing for, at least, last 6 months

Exclusion Criteria:

  • smoking
  • contraindications to BJ diet
  • physical limitations, health problems, or musculoskeletal injuries

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: BJ supplementation
Dietary supplement: Beetroot Juice (BJ) acute supplementation
One serving of 70 mL of BJ (6.4 mmol of NO3) 3h before initiating the testing session
Placebo Comparator: PLA supplementation
Dietary supplement: Placebo Juice (PLA) acute supplementation
One serving of 70 mL of juice (0.005 mmol of NO3) 3h before initiating the testing session

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in rate of force development (N/s) at 50, 100 and 200 ms; and at 95% of maximal force
Time Frame: 1 week
Using a force sensor
1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in maximal jump height (cm)
Time Frame: 1 week
Maximal jump height using a contact platform
1 week
Changes in maximal isometric handgrip strength (kg)
Time Frame: 1 week
Using a dynamometer
1 week
Changes in nitrites and nitrates levels in saliva (μmol/L)
Time Frame: 1 week
Using specific kit ELISA analysis
1 week
Changes in maximal number of pull-ups
Time Frame: 1 week
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad Francisco de Vitoria

Investigators

  • Principal Investigator: Luis Berlanga, Universidad Francisco de Vitoria

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2021

Primary Completion (Actual)

November 15, 2021

Study Completion (Actual)

November 30, 2021

Study Registration Dates

First Submitted

January 25, 2022

First Submitted That Met QC Criteria

January 26, 2022

First Posted (Actual)

January 27, 2022

Study Record Updates

Last Update Posted (Actual)

January 27, 2022

Last Update Submitted That Met QC Criteria

January 26, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • UFV2020-44

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe